I-MED Radiology Network

I-MED Radiology Network

I-MED Radiology Network was formed in 2000 through the merger of several Australian radiology groups. It functions as a corporate consolidator in healthcare services, buying independent radiology and medical imaging practices and integrating them into a single operating platform. The network spans clinics in metropolitan and regional Australia, offering X-ray, CT, MRI, ultrasound, nuclear medicine, and interventional radiology. I-MED pursues a buy-and-build strategy: acquire founder-operated radiology clinics, standardize backend systems, centralize purchasing of expensive imaging equipment — MRI and CT scanners from OEMs like Siemens and GE — and pool radiologist capacity across sites to improve equipment utilization. The model relies on Australia's mixed public-private healthcare funding, with revenue streams from Medicare bulk-billing, private health insurers, and workers' compensation schemes. In June 2018, Permira acquired I-MED for roughly A$1.25 billion from a consortium led by Anchorage Capital Partners and the Ontario Teachers' Pension Plan, valuing the business at one of the largest healthcare services transactions in Australian history (per Australian Financial Review, 2018). The deal demonstrated private equity's thesis that Australia's dispersed diagnostic imaging market — long dominated by sole practitioners — could sustain a scaled corporate operator. Post-acquisition, Permira supported I-MED's continued clinic acquisitions and investment in teleradiology to connect rural sites with metropolitan-based subspecialist radiologists. The network employs or contracts over 250 radiologists and serves hospitals, referring GPs, and specialist physicians. It also operates its own registrar training program to partially self-supply the pipeline of radiologists in a persistently tight Australian labor market for medical specialists. In 2023, Permira explored exit options for I-MED, including a potential trade sale or initial public offering on the ASX, though no transaction materialized (per The Australian, 2023). I-MED's structural differentiator is that it is not a fund or investment vehicle raising outside capital — it is a single operating company held by a private equity sponsor and run as an integrated healthcare business. The network's value creation levers are operational: practice acquisition at fragmented-seller multiples, margin expansion through centralized procurement and billing, and clinical workforce optimization across a footprint that individual practices could not achieve alone.